Lynn Seely

Insider Reports History

Entity
Individual
Location
501 2 Nd Street, Suite 211, San Francisco, CA
Signature
/s/ Melissa Masse
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lynn Seely:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Blueprint Medicines Corp Director Common Stock 13.3K $1.39M $105.13 Jun 12, 2024 Direct
Lyell Immunopharma, Inc. President and CEO, Director Common Stock 200K $456K $2.28 Feb 9, 2024 Direct
Blueprint Medicines Corp Director Stock Option (Right to Buy) 4.57K $68.6K $15.01 Jun 12, 2024 Direct
Lyell Immunopharma, Inc. President and CEO, Director Stock Option (right to buy) 0 Nov 16, 2023 Direct

Insider Reports Filed by Lynn Seely

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BPMC Blueprint Medicines Corp Jun 12, 2024 2 $0 4 Jun 14, 2024 Director
LYEL Lyell Immunopharma, Inc. Feb 9, 2024 1 $0 4 Feb 13, 2024 President and CEO, Director
LYEL Lyell Immunopharma, Inc. Nov 16, 2023 2 $0 4 Nov 20, 2023 President and CEO, Director
BPMC Blueprint Medicines Corp Jun 21, 2023 2 $0 4 Jun 23, 2023 Director
LYEL Lyell Immunopharma, Inc. Dec 15, 2022 1 $0 4 Dec 19, 2022 President and CEO, Director
BPMC Blueprint Medicines Corp Jun 21, 2022 2 $0 4 Jun 30, 2022 Director
LYEL Lyell Immunopharma, Inc. Jun 8, 2022 1 $0 4 Jun 10, 2022 Director
LYEL Lyell Immunopharma, Inc. Jun 16, 2021 0 $0 3 Jun 16, 2021 Director
BPMC Blueprint Medicines Corp Jun 2, 2021 2 $0 4 Jun 4, 2021 Director